Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Blood

• Publication date

  1995-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V85.12.3636.BLOODJOURNAL85123636PMID 7780147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.

  1994cited by this paper
• Superfibronectin is a functionally distinct form of fibronectin

  1994cited by this paper
• Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.

  1993cited by this paper
• The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL.

  1993cited by this paper
• Membrane-anchored growth factors.

  1993cited by this paper
• Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures.

  1993cited by this paper
• A new in situ hybridization technique for spliced RNA species documents the bone marrow origin of pulmonary macrophages in chronic myelogenous leukemia.

  1992cited by this paper
• Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression.

  1992cited by this paper
• Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis.

  1992cited by this paper
• Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.

  1992cited by this paper
• Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells.

  1992cited by this paper
• Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.

  1992cited by this paper
• Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells.

  1991cited by this paper
• Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.

  1991cited by this paper
• Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin

  1991cited by this paper
• Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors.

  1991cited by this paper
• Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression.

  1991cited by this paper
• bcr/abl mRNA DETECTION FOLLOWING BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

  1991cited by this paper
• Bone marrow stromal cell changes in haematological malignancies.

  1990cited by this paper
• Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma

  1990cited by this paper
• Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs

  1990cited by this paper
• Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stroma.

  1990cited by this paper
• Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

  1990cited by this paper
• Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

  1990cited by this paper
• Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression

  1989cited by this paper
• Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

  1988cited by this paper
• Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

  1988cited by this paper
• Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

  1987cited by this paper
• Host origin of marrow stromal cells following allogeneic bone marrow transplantation

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Cell-type-specific fibronectin subunits generated by alternative splicing.

  1986cited by this paper
• Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.

  1986cited by this paper
• Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses.

  1986cited by this paper
• Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures.

  1985cited by this paper
• A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures.

  1985cited by this paper
• Chronic myelocytic leukemia: ultrastructural histopathology of bone marrow from patients in the chronic phase.

  1984cited by this paper
• A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

  1982cited by this paper
• Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

  1981cited by this paper
• Cytogentics of fibroblastic colonies in Ph1-positive chronic myelogenous leukemia.

  1978cited by this paper

• The Role of the Bone Marrow Microenvironment in Leukemic Stem Cell Resistance: Pathways of Persistence and Selection.

  2025cites this paper
• Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies

  2025cites this paper
• Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity

  2024influential citation
• An emerging role of N-glycosylation in cancer chemoresistance.

  2024cites this paper
• Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis

  2023cites this paper
• Secondary Acute Myeloid Leukemia in a Chronic Myeloid Leukemia Patient in Deep Molecular Response—An Unusual Case Report

  2022cites this paper
• The cytokine network in acute myeloid leukemia

  2022cites this paper
• Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies

  2022cites this paper
• Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors

  2021cites this paper
• TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling

  2021cites this paper
• Advances in culture methods for acute myeloid leukemia research

  2021cites this paper
• Recent progress on targeting leukemia stem cells.

  2021cites this paper
• BCR::ABL1‐positive histiocytic sarcoma of the small intestine in a patient with chronic myeloid leukaemia

  2021influential citation
• The Etiology of Cancer

  2020cites this paper
• Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches

  2020cites this paper
• Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.

  2020cites this paper
• Biologic profile evaluation of mesenchymal stem cells in co-culture with K562 cells

  2020cites this paper
• Functional expression cloning of molecules inducing CD34 expression in bone marrow-derived stromal myofibroblasts.

  2020cites this paper
• Tyrosine kinase inhibitors and interferon‐α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines

  2020cites this paper
• SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia

  2020cites this paper
• Chronic myelogenous leukemia stem cells require cell-autonomous pleiotrophin signaling.

  2019influential citation
• Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling

  2019cites this paper
• CHANGES IN STROMAL PROGENITOR CELLS DERIVED FROM BONE MARROW IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA AT THE ONSET OF THE DISEASE AND DURING TREATMENT

  2019cites this paper
• Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia

  2019cites this paper
• Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.

  2019cites this paper
• Mass spectrometry and proteomics in hematology.

  2019cites this paper
• 2 Inflammatory ROS in Fanconi Anemia Hematopoiesis and Leukemogenesis

  2018cites this paper
• Bone Marrow Niche Trafficking of miR-126 Controls Self-Renewal of Leukemia Stem Cells in Chronic Myelogenous Leukemia

  2018cites this paper
• INCREASED ADHESION OF CML CELLS BY ABL1 TYROSINE KINASE

  2018cites this paper
• Inflammatory ROS in Fanconi Anemia Hematopoiesis and Leukemogenesis

  2018cites this paper
• : Chronic Myeloid Leukemia : Stem Cell Niche and Response to Pharmacologic Treatment

  2018cites this paper
• Interferon Alpha and Kinase Inhibitor Nilotinib Increase Cell Adhesion and Tunneling Nanotubes in CML

  2018cites this paper
• Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment

  2017cites this paper
• Kinase Inhibitor Screening in Myeloid Malignancies.

  2017cites this paper
• Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI.

  2017cites this paper
• DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.

  2017cites this paper
• Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.

  2017cites this paper
• Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies

  2016cites this paper
• Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia

  2016cites this paper
• TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy

  2016cites this paper
• Biology of Hematopoietic Stem Cell Niche

  2015cites this paper
• Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients

  2015cites this paper
• Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy.

  2015cites this paper
• Characterization of bone marrow mesenchymal stromal cells in aplastic anaemia

  2015cites this paper
• JAK 2 / STAT 5 inhibition by nilotinib with ruxolitinib contributes to the elimination of chronic phase CML CD 34 + cells in vitro and in vivo

  2014cites this paper
• Role of matriptase (ST14) in chronic myeloid leukaemia.

  2014cites this paper
• MYELOID NEOPLASIA JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34 + cells in vitro and in vivo

  2014cites this paper
• The role of cytokines in governing the expansion of the T315I mutation in chronic myeloid leukaemia.

  2014influential citation
• Assessment of Interleukin 1β Serum Level in Different Responder Groups and Stages of Chronic Myeloid Leukemia Patients on Imatinb Mesylate Therapy

  2014cites this paper
• Comparative characteristics of amniotic membrane, endometrium and ovarian derived mesenchymal stem cells: A role for amniotic membrane in stem cell therapy

  2014cites this paper
• JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.

  2014cites this paper
• [Bone marrow microenvironment in chronic myeloid leukemia: implications for disease physiopathology and response to treatment].

  2014cites this paper
• MDS Stem Cell Biology

  2013cites this paper
• following imatinib mesylate treatment myelogenous leukemia patients in complete cytogenetic remission Persistence of malignant hematopoietic progenitors in chronic

  2013cites this paper
• ХРОМОСОМНЫЕ АНОМАЛИИ В КРОВЕТВОРНЫХ И СТРОМАЛЬНЫХ КЛЕТКАХ- ПРЕДШЕСТВЕННИКАХ ПРИ МИЕЛОДИСПЛАСТИЧЕСКОМ СИНДРОМЕ

  2013cites this paper
• Investigation of the role of autocrine and paracrine growth factors in the survival and proliferation of chronic myeloid leukaemia stem and progenitor cells

  2013cites this paper
• Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice

  2013cites this paper
• The role of tumour–stromal interactions in modifying drug response: challenges and opportunities

  2013cites this paper
• The hematopoietic stem cell niche—home for friend and foe?

  2013influential citation
• Surface morphology of leukemic cells from chronic myeloid leukemia under atomic force microscopy

  2013cites this paper
• and imatinib sensitivity of transformed human hematopoietic cells Role of BCR/ABL gene-expression levels in determining the phenotype

  2013cites this paper
• T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.

  2013cites this paper
• Cancer drug resistance: an evolving paradigm

  2013cites this paper
• Development of biomimetic PHB and PHBV scaffolds for a three dimensional (3-D) in vitro human leukaemia model

  2013cites this paper
• IMMUNOBIOLOGY T cells expressing CD 123-speci fi c chimeric antigen receptors exhibit speci fi c cytolytic effector functions and antitumor effects against human acute myeloid leukemia

  2013cites this paper
• Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders

  2012cites this paper
• Label‐free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: disclosing new insights from therapy resistance

  2012cites this paper
• Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.

  2012cites this paper
• Inflammatory ROS in Fanconi Anemia Hematopoiesis and Leukemogenesis

  2012cites this paper
• Issues in Development

  2012cites this paper
• Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors

  2012cites this paper
• Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia.

  2012cites this paper
• Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity

  2012cites this paper
• Inflammatory ROS in Fanconi Anemia Hematopoiesis and Leukemogenesis

  2012cites this paper
• Exosomes released by K 562 chronic myeloid leukemia cells promote endothelial cell tubular differentiation through uptake and cell-to-cell transfer

  2011cites this paper
• A critical role for SHP 2 in STAT 5 activation and growth factor – mediated proliferation , survival , and differentiation of human CD 34 cells

  2011cites this paper
• Bone Marrow Microenvironment in the Pathogenesis of AML

  2011cites this paper
• A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

  2011cites this paper
• The Stem Cell Niche: The Black Master of Cancer

  2011cites this paper
• Chronic myelogenous leukemia cells convert to myofibroblasts in vitro: effect of vascular endothelial growth factor on development of the microenvironment.

  2011cites this paper
• Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia

  2011cites this paper
• Hematogones are markedly decreased in chronic myeloid leukemia: multiparametric flow cytometric analysis

  2011cites this paper
• Role of immune responses in the pathogenesis of low‐risk MDS and high‐risk MDS: implications for immunotherapy

  2011cites this paper
• progenitors and K562 cells fibronectin decreases proliferation of chronic myelogenous leukemia Activation-dependent alpha5beta1 integrin-mediated adhesion to

  2010cites this paper
• The bone marrow microenvironment as a sanctuary for minimal residual disease in CML.

  2010cites this paper
• The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia.

  2010cites this paper
• Neoplastic stem cells: current concepts and clinical perspectives.

  2010cites this paper
• Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells

  2010cites this paper
• Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate.

  2010cites this paper
• Acute myelogenous leukemia cells with the MLL-ELL translocation convert morphologically and functionally into adherent myofibroblasts.

  2010cites this paper
• Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl

  2010cites this paper
• Cancer stem cells: the emerging challenge of drug targeting.

  2009cites this paper
• A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease

  2009cites this paper
• In vitro biology of human myeloid leukemia.

  2009cites this paper
• Role of BCR-ABL-Y177 mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors

  2009cites this paper
• Long-term culture of leukemic bone marrow primary cells in biomimetic osteoblast niche

  2009cites this paper
• Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.

  2009influential citation
• CML: a model for targeted therapy.

  2009cites this paper
• Hematopoiesis Capacity, Immunomodulatory Effect and Ex Vivo Expansion Potential of Mesenchymal Stem Cells Are Not Impaired by Cryopreservation

  2008cites this paper
• Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors

  2008cites this paper